No Data
No Data
Earnings Preview: TMCI to Report Financial Results Post-market on November 05
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
Truist Financial Maintains Treace Medical Concepts(TMCI.US) With Hold Rating, Cuts Target Price to $6
Express News | Treace Medical Concepts Inc - Expects Adjusted Ebitda Breakeven in 2025
Express News | Treace Medical Concepts Inc - Expects 2024 Adjusted Ebitda to Improve 50% Compared to 2023
Treace Files Patent Infringement and Unfair Competition Suit Against Stryker to Protect Lapiplasty Bunion Technology
No Data
No Data